EU Pharma Strategy To Balance Innovation Incentives & Competition
Stakeholders Have Different Views On ‘Unmet Medical Need’
Delegates at this week’s TOPRA conference heard the European Commission’s “holistic” vision of what it would like to achieve through its pharmaceutical strategy, including incentives for innovation, security of the supply chain, product shortages, real world evidence and big data, and the availability and affordability of medicines.
